Clinical outcome of nivolumab in older and frail patients with recurrent/metastatic head and neck squamous cell carcinoma

被引：1
|
作者：
Becherini, Carlotta [1 ]
Banini, Marco [2 ,3 ]
Desideri, Isacco [2 ]
Salvestrini, Viola [2 ]
Caprara, Luisa [2 ]
Scotti, Vieri [1 ]
Ganovelli, Michele [2 ]
Morelli, Ilaria [2 ]
Romei, Andrea [2 ]
Livi, Lorenzo [1 ,2 ]
Bonomo, Pierluigi [1 ]
机构：
[1] Azienda Osped Univ Careggi, Radiat Oncol Dept, Florence, Italy
[2] Univ Florence, Dept Biomed Expt & Clin Sci Mario Serio, Florence, Italy
[3] Univ Florence, Radiat Oncol Dept, AOU Careggi, Lgo Brambilla 3, I-50134 Florence, Italy
来源：
JOURNAL OF GERIATRIC ONCOLOGY | 2023年 / 14卷 / 01期
关键词：
Nivolumab; Older patients; Immunotherapy; Geriatric oncology; Head and neck cancer; CANCER; CHEMOTHERAPY; MANAGEMENT; CETUXIMAB; RECURRENT;
D O I：
10.1016/j.jgo.2022.09.009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Prognostic Factors in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
    Haring, C. T.
    Rosko, A.
    Heft-Neal, M. E.
    Shuman, A.
    Brenner, J. C.
    Worden, F.
    Spector, M. E.
    Swiecicki, P. L.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (05): : 1177 - 1177
  • [42] Pembrolizumab and afatinib for recurrent or metastatic head and neck squamous cell carcinoma
    Kao, H-F.
    Hong, R-L.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 : 379 - 379
  • [43] Maintenance immunotherapy in recurrent or metastatic squamous cell carcinoma of the head and neck
    Recchia, Francesco
    Candeloro, Giampiero
    Di Staso, Mario
    Necozione, Stefano
    Bisegna, Roberta
    Bratta, Massimo
    Tombolini, Vincenzo
    Rea, Silvio
    [J]. JOURNAL OF IMMUNOTHERAPY, 2008, 31 (04) : 413 - 419
  • [44] Vinorelbine and carboplatin in recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Kornek, V
    Scheithauer, W
    Glaser, C
    Toth, J
    Duman, M
    Formanek, M
    Hejna, M
    Kornfehl, J
    [J]. ONCOLOGY, 1999, 56 (01) : 24 - 27
  • [45] Optimizing treatments for recurrent or metastatic head and neck squamous cell carcinoma
    Specenier, Pol
    Vermorken, Jan B.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (09) : 901 - 915
  • [46] Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma
    Hedberg, Matthew L.
    Goh, Gerald
    Chiosea, Simion I.
    Bauman, Julie E.
    Freilino, Maria L.
    Zeng, Yan
    Wang, Lin
    Diergaarde, Brenda B.
    Gooding, William E.
    Lui, Vivian W. Y.
    Herbst, Roy S.
    Lifton, Richard P.
    Grandis, Jennifer R.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (01): : 169 - 180
  • [47] Optimizing Treatment for Head and Neck Cancers: Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
    Haddad, Robert, I
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (07): : 982 - 984
  • [48] Nomogram to predict duration of clinical benefit from nivolumab in platinum resistant, recurrent/metastatic head and neck squamous cell carcinoma.
    Feeney, Laura
    Rack, Samuel
    Mistry, Hitesh
    Bola, Becky
    McPartlin, Andrew
    Sykes, Andrew
    Metcalf, Robert
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18016 - E18016
  • [49] Role of eosinophilia in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab: Prediction of immune-related adverse events and favorable outcome
    Ueki, Yushi
    Ohshima, Shusuke
    Omata, Jo
    Yokoyama, Yusuke
    Takahashi, Takeshi
    Shodo, Ryusuke
    Yamazaki, Keisuke
    Horii, Arata
    [J]. CANCER MEDICINE, 2023, 12 (22): : 20810 - 20820
  • [50] Nutritional status associates with immunotherapy clinical outcomes in recurrent or metastatic head and neck squamous cell carcinoma patients
    Hernando-Calvo, Alberto
    Mirallas, Oriol
    Marmolejo, David
    Saavedra, Omar
    Vieito, Maria
    Pastrana, Juan David Assaf
    Aguilar, Susana
    Bescos, Coro
    Lorente, Juan
    Giralt, Jordi
    Benavente, Sergi
    Temprana-Salvador, Jordi
    Alberola, Margarita
    Dienstmann, Rodrigo
    Garralda, Elena
    Felip, Enriqueta
    Villacampa, Guillermo
    Brana, Irene
    [J]. ORAL ONCOLOGY, 2023, 140
12345